Terms: = Head and neck cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Clinical Outcome
40 results:
1. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
Hu J; Huang Q; Hu W; Liang F; Gao J; Yang J; Qiu X; Zhang H; Zhang G; Lu JJ; Kong L
Oral Oncol; 2024 Apr; 151():106683. PubMed ID: 38387259
[TBL] [Abstract] [Full Text] [Related]
2. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Negrao MV; Araujo HA; Lamberti G; Cooper AJ; Akhave NS; Zhou T; Delasos L; Hicks JK; Aldea M; Minuti G; Hines J; Aredo JV; Dennis MJ; Chakrabarti T; Scott SC; Bironzo P; Scheffler M; Christopoulos P; Stenzinger A; Riess JW; Kim SY; Goldberg SB; Li M; Wang Q; Qing Y; Ni Y; Do MT; Lee R; Ricciuti B; Alessi JV; Wang J; Resuli B; Landi L; Tseng SC; Nishino M; Digumarthy SR; Rinsurongkawong W; Rinsurongkawong V; Vaporciyan AA; Blumenschein GR; Zhang J; Owen DH; Blakely CM; Mountzios G; Shu CA; Bestvina CM; Garassino MC; Marrone KA; Gray JE; Patel SP; Cummings AL; Wakelee HA; Wolf J; Scagliotti GV; Cappuzzo F; Barlesi F; Patil PD; Drusbosky L; Gibbons DL; Meric-Bernstam F; Lee JJ; Heymach JV; Hong DS; Heist RS; Awad MM; Skoulidis F
Cancer Discov; 2023 Jul; 13(7):1556-1571. PubMed ID: 37068173
[TBL] [Abstract] [Full Text] [Related]
3. clinical outcome-Related cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
Li L; Sun J; Liu N; Yu R; Zhang J; Pang J; Ou Q; Yin Y; Cui J; Yao X; Zhao R; Shao Y; Yuan S; Yu J
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):382-394. PubMed ID: 36167753
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
Wardana T; Oktriani R; Murjayanto CH; Putri DU; Anwar SL; Aryandono T; Haryana SM
Microrna; 2023; 12(1):29-44. PubMed ID: 36121076
[TBL] [Abstract] [Full Text] [Related]
5. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract] [Full Text] [Related]
6. Oncogenic role of MiR-130a in oral squamous cell carcinoma.
Mallela K; Shivananda S; Gopinath KS; Kumar A
Sci Rep; 2021 Apr; 11(1):7787. PubMed ID: 33833339
[TBL] [Abstract] [Full Text] [Related]
7. Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma.
Li Y; Jiang X; Yan X; Wang Y
Thorac Cancer; 2021 Mar; 12(6):752-759. PubMed ID: 33481352
[TBL] [Abstract] [Full Text] [Related]
8. Significance of druggable targets (PD-L1, KRAS, BRAF, pik3ca, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
[TBL] [Abstract] [Full Text] [Related]
9. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
[TBL] [Abstract] [Full Text] [Related]
10. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict clinical outcome after Surgical Treatment of head and neck Squamous Cell Carcinoma.
Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
[TBL] [Abstract] [Full Text] [Related]
11. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing pi3k/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract] [Full Text] [Related]
12. miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of pi3k-Akt-NF-kB pathway in tongue squamous cell carcinoma.
Gu Y; Liu H; Kong F; Ye J; Jia X; Zhang Z; Li N; Yin J; Zheng G; He Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):164. PubMed ID: 30041677
[TBL] [Abstract] [Full Text] [Related]
13. The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
Urano M; Hirai H; Tada Y; Kawakita D; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Sato Y; Saigusa N; Nakaguro M; Hanazawa T; Nagao T
Histopathology; 2018 Dec; 73(6):943-952. PubMed ID: 29993139
[TBL] [Abstract] [Full Text] [Related]
14. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic role of pik3ca and TP53 in human papillomavirus-negative oropharyngeal cancers.
Resteghini C; Perrone F; Miceli R; Bergamini C; Alfieri S; Orlandi E; Guzzo M; Granata R; Galbiati D; Cavalieri S; Locati L; Licitra L; Bossi P
Tumori; 2018 Jun; 104(3):213-220. PubMed ID: 29714670
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of pik3ca in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
[TBL] [Abstract] [Full Text] [Related]
17. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory pi3k/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract] [Full Text] [Related]
18. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract] [Full Text] [Related]
19.
Liu SY; Chen W; Chughtai EA; Qiao Z; Jiang JT; Li SM; Zhang W; Zhang J
World J Gastroenterol; 2017 Apr; 23(14):2585-2591. PubMed ID: 28465643
[TBL] [Abstract] [Full Text] [Related]
20. The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.
Openshaw MR; Richards CJ; Guttery DS; Shaw JA; Thomas AL
Expert Rev Mol Diagn; 2017 May; 17(5):459-470. PubMed ID: 28306358
[TBL] [Abstract] [Full Text] [Related]
[Next]
